Clinical trial
Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer…
NCT00375076 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00375076 |
|---|---|
| Title | Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients |
| Official title | Prevention of Venous Thrombosis in Cancer Patients: A Prospective, Randomized, Double-blind Study Comparing Two Different Dosages of Low-molecular Weight Heparin |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | enoxaparin |
| Start date | Jun 1, 2006 |
| Completion | May 1, 2008 |
| First posted | Sep 12, 2006 |
| Last update posted | Sep 18, 2009 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: